Macrogenics Inc
(NAS:MGNX)
$
2.98
-0.08 (-2.61%)
Market Cap: 186.91 Mil
Enterprise Value: 87.18 Mil
PE Ratio: 0
PB Ratio: 3.24
GF Score: 50/100 
MacroGenics Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
Nov 12, 2019 / 04:10PM GMT
Release Date Price:
$8.25
(+3.77%)
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
(technical difficulty)
at Crédit Suisse. It is my pleasure to have MacroGenics with us for a fireside chat on the first day of our 2019 healthcare conference.
And from MacroGenics, I've Scott Koenig, President and CEO. Thank you for joining us in Scottsdale.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Thank you very much, Evan.
Questions & Answers
Evan David Seigerman;dit Suisse AG
CrÃ;Research Division - VP & Senior Equity Research Analyst
© -
So just before we dive into some of the data, can you give us an update as to kind of the progress you've had this year? And what are some things that investors should be focusing on when it comes to the MacroGenics story? That could be a half-hour, I guess.
Scott Koenig
MacroGenics, Inc. - CEO, President & Director
Yes
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers